|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetic Macular Edema | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Edema | |||||
| Macular Edema | |||||
| 3 | More general conditions related to this trial | ||||
| Eye Diseases | |||||
| Macular Degeneration | |||||
| Retinal Degeneration | |||||
| Retinal Diseases | |||||
| Signs and Symptoms | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Fluocinolone Acetonide | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Inflammatory Agents | |||||
| Glucocorticoids | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Bausch &Lomb, Inc. | |||||